Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:35 AM UTC
| NCT Number | NCT05168566 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 99 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Teligene US |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of July 18, 2026: Clinical trial NCT05168566 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Teligene US. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05168566 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05168566 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.